1. Home
  2. EXPI vs CERT Comparison

EXPI vs CERT Comparison

Compare EXPI & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$6.72

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$6.22

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
CERT
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
860.9M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
EXPI
CERT
Price
$6.72
$6.22
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$9.75
$11.67
AVG Volume (30 Days)
875.3K
4.3M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
$500,147,681.00
$418,838,000.00
Revenue This Year
$6.26
$4.18
Revenue Next Year
$5.50
$5.39
P/E Ratio
N/A
N/A
Revenue Growth
220.39
8.75
52 Week Low
$5.66
$5.19
52 Week High
$12.23
$15.38

Technical Indicators

Market Signals
Indicator
EXPI
CERT
Relative Strength Index (RSI) 62.47 52.79
Support Level $5.68 $6.04
Resistance Level $11.36 $7.52
Average True Range (ATR) 0.23 0.29
MACD 0.14 0.13
Stochastic Oscillator 98.07 86.27

Price Performance

Historical Comparison
EXPI
CERT

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: